Proteomics for cancer drug design-Reference-Cited by-同舟云学术

Proteomics for cancer drug design

Published:2019-08-03 Issue:8 Volume:16 Page:647-664
ISSN:1478-9450
Container-title:Expert Review of Proteomics
language:en
Short-container-title:Expert Review of Proteomics

Author:

Haymond Amanda¹,Davis Justin B.¹,Espina Virginia¹^ORCID

Affiliation:

1. Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA

Publisher

Informa UK Limited

Subject

Molecular Biology,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/14789450.2019.1650025

Reference119 articles.

1. Precision medicine [Internet]. Natl Cancer Inst. 2015. [cited 2018 Dec 7]. Available from: https://www.cancer.gov/about-cancer/treatment/types/precision-medicine

2. Next generation antibody drugs: pursuit of the 'high-hanging fruit'

3. The Use of Antibodies in Small-Molecule Drug Discovery

4. Click chemistry enables preclinical evaluation of targeted epigenetic therapies

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of cancer data fusion methods based on deep learning;Information Fusion;2024-08

2. Computational resources and chemoinformatics for translational health research;Advances in Protein Chemistry and Structural Biology;2024

3. Omics Applications in Cancer Immunology;Handbook of Cancer and Immunology;2024

4. Precision clinical genomics and single subject studies of multi-omics data;Comprehensive Precision Medicine;2024

5. Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice;Proteomes;2023-01-10